• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600

    11/22/21 6:01:00 PM ET
    $EBS
    $SITM
    $SPGI
    $UFS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $EBS alert in real time by email

    NEW YORK, Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: SITM) will replace Emergent BioSolutions Inc. (NYSE:EBS) in the S&P MidCap 400, and Emergent BioSolutions will replace Domtar Corp. (NYSE:UFS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, November 30. Paper Excellence B.V. is acquiring Domtar in a deal expected to be completed soon pending final conditions. Emergent BioSolutions is more representative of the small-cap market space.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Nov 30, 2021

    S&P MidCap 400

    Addition

    SiTime

    SITM

    Information Technology



    S&P MidCap 400

    Deletion

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Addition

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Deletion

    Domtar

    UFS

    Materials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/sitime-set-to-join-sp-midcap-400-emergent-biosolutions-to-join-sp-smallcap-600-301430362.html

    SOURCE S&P Dow Jones Indices

    Get the next $EBS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EBS
    $SITM
    $SPGI
    $UFS

    CompanyDatePrice TargetRatingAnalyst
    SiTime Corporation
    $SITM
    8/14/2025$260.00Buy
    UBS
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    Emergent BioSolutions Inc.
    $EBS
    12/30/2024$15.00Buy
    H.C. Wainwright
    S&P Global Inc.
    $SPGI
    12/20/2024$600.00Buy
    Citigroup
    S&P Global Inc.
    $SPGI
    10/2/2024$599.00Outperform
    Evercore ISI
    S&P Global Inc.
    $SPGI
    9/23/2024Outperform → Mkt Perform
    Raymond James
    SiTime Corporation
    $SITM
    8/27/2024$90.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    5/15/25 4:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    6/17/24 4:04:40 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on SiTime with a new price target

    UBS initiated coverage of SiTime with a rating of Buy and set a new price target of $260.00

    8/14/25 8:04:12 AM ET
    $SITM
    Semiconductors
    Technology

    BofA Securities resumed coverage on S&P Global with a new price target

    BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

    4/10/25 8:19:38 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Mizuho initiated coverage on S&P Global with a new price target

    Mizuho initiated coverage of S&P Global with a rating of Outperform and set a new price target of $599.00

    3/12/25 7:34:28 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zoon Kathryn C sold $62,853 worth of shares (7,086 units at $8.87), decreasing direct ownership by 9% to 71,799 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    8/18/25 4:33:31 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Degolyer Donald W sold $67,831 worth of shares (7,844 units at $8.65), decreasing direct ownership by 5% to 137,659 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    8/13/25 4:22:58 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, Market Intelligence Saha Saugata sold $1,122,240 worth of shares (2,000 units at $561.12), decreasing direct ownership by 39% to 3,150 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    8/12/25 4:01:41 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    S&P Global and Maestro Partner to Offer Private Equity Firms Enhanced Visibility into Asset Level Performance

    Partnership offers streamlined value creation monitoring and reporting to support decision-making NEW YORK, Aug. 19, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) and Maestro, the leading Value Creation Management platform for private equity and a S&P Global Ventures portfolio company, have announced a strategic partnership to deliver enhanced portfolio monitoring capabilities for private equity firms and their portfolio companies. This partnership includes a native integration of the Maestro platform with S&P Global's iLEVEL portfolio monitoring system, enabling automated data entry and streamlined measurement of value creation initiatives.

    8/19/25 12:09:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Asia Pacific Petroleum Conference (APPEC) to Address Key Industry Issues Facing Global Energy Markets

    Premier energy summit set for September to focus on 'Navigating Trade, Technology and Transition" SINGAPORE, Aug. 15, 2025 /PRNewswire/ -- The 41st annual Asia Pacific Petroleum Conference (APPEC) by S&P Global – Asia's leading energy conference - will take place from September 8 to 11, 2025, at the Raffles City Convention Centre in Singapore. A cornerstone of the energy industry for the past 40 years, this premier gathering of close to 1,500 industry leaders, experts and executives across 65 countries aims to explore the evolving landscape of the oil and gas sector, discussin

    8/15/25 7:01:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    SEC Filings

    View All

    SEC Form EFFECT filed by Emergent BioSolutions Inc.

    EFFECT - Emergent BioSolutions Inc. (0001367644) (Filer)

    8/18/25 12:15:25 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Emergent BioSolutions Inc.

    144 - Emergent BioSolutions Inc. (0001367644) (Subject)

    8/15/25 4:04:54 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by Emergent BioSolutions Inc.

    S-3 - Emergent BioSolutions Inc. (0001367644) (Filer)

    8/7/25 4:15:37 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    Kodiak Gas Services Set to Join S&P SmallCap 600

    NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Kodiak Gas Services Inc. (NYSE:KGS) will replace NV5 Global Inc. (NASD: NVEE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, August 06. Acuren Corp. (NYSE:TIC) is acquiring NV5 Global in a deal expected to be completed soon pending final conditions.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector August 06, 2025 S&P SmallCap 600 Addition Kodiak Gas Services KGS Energy August 06, 2025 S&P SmallCap 600 Deletion NV5 Global NVEE Industrials For more information about S&P Dow Jones Indices, please v

    8/1/25 5:54:00 PM ET
    $KGS
    $NVEE
    $SPGI
    Natural Gas Distribution
    Utilities
    Other Consumer Services
    Consumer Discretionary

    Veracyte Set to Join S&P SmallCap 600

    NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE:TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners LLC will acquire Triumph Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector July 29, 2025 S&P SmallCap 600 Addition Veracyte VCYT Health Care July 29, 2025 S&P SmallCap 600 Deletion Triumph Group TGI Industrials For more information about S&P Dow Jones Indices,

    7/24/25 5:58:00 PM ET
    $SPGI
    $TGI
    $VCYT
    Finance: Consumer Services
    Finance
    Aerospace
    Industrials

    $EBS
    $SITM
    $SPGI
    $UFS
    Financials

    Live finance-specific insights

    View All

    SiTime Reports Second Quarter 2025 Financial Results

    Q2 Net Revenue Increased 58% to $69.5 Million SiTime Corporation, (NASDAQ:SITM), the Precision Timing company, today announced financial results for the second quarter ended June 30, 2025. Net revenue in the second quarter of 2025 was $69.5 million, as compared to $43.9 million in the year ago quarter. "SiTime's continued momentum across our end markets demonstrates that our focus on high performance applications is working," said Rajesh Vashist, CEO and chairman of SiTime. "Revenue from our Communications, Enterprise, and Data Center market (CED) grew 137% year over year, fueled by AI that created strong demand for our Precision Timing solutions." In the second quarter of 2025, GAA

    8/6/25 4:38:00 PM ET
    $SITM
    Semiconductors
    Technology

    Emergent BioSolutions Reports Second Quarter 2025 Financial Results

    Second Quarter 2025 Total Revenues of $140.9 million, above Q2 guidance by $21 millionSecond Quarter 2025 Net Loss of $12.0 million and Net Loss Margin of (9)%, an improvement of 96% and 10,200 bps, respectively, versus prior yearSecond Quarter 2025 Gross Margin % of 36% and Adjusted Gross Margin % of 49%, an expansion of 6,200 bps and 2,300 bps, respectively, versus prior yearSecond Quarter 2025 Adjusted EBITDA of $28.5 million, an increase of 382% versus prior yearSecond Quarter 2025 Adjusted EBITDA Margin of 20% of Total Revenues, an improvement of 2,400 bps versus prior yearRaising the low end/midpoint of Full Year 2025 Profitability Guidance GAITHERSBURG, Md., Aug. 06, 2025 (GLOBE NE

    8/6/25 4:15:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bill Eager Appointed President of S&P Global Mobility and CEO Designate of Planned Standalone Public Company

    Edouard Tavernier to Transition to Strategic Advisor Role Through September 30, 2025Company Separately Reports Second Quarter 2025 Results; Conference Call Today at 8:30 a.m. EDTNEW YORK, July 31, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the appointment of Bill Eager, Chief Executive Officer of CARFAX, as President of S&P Global Mobility ("Mobility"), effective August 15, 2025, and CEO designate upon completion of the previously announced planned separation of Mobility into a standalone public company. Mr. Eager succeeds Edouard Tavernier, who will remain with the Company as a strategic advisor through September 30, 2025, to support a smooth transition.

    7/31/25 7:17:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Emergent BioSolutions Inc.

    SC 13G - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/13/24 4:00:18 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiTime Corporation

    SC 13G/A - SITIME Corp (0001451809) (Subject)

    11/12/24 10:34:18 AM ET
    $SITM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Emergent BioSolutions Inc.

    SC 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/8/24 5:23:28 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care